Page 28 - Read Online
P. 28

Mimouni et al. Rare Dis Orphan Drugs J 2024;3:17  https://dx.doi.org/10.20517/rdodj.2024.06   Page 9 of 10

               16.      EJP RD. Rare diseases research (RDR) challenges call. Available from: https://www.ejprarediseases.org/rare-diseases-challenges/
                   [Last accessed on 17 Jun 2024].
               17.      EJP RD. Funded projects: internal call for proposals 2019 - clinical trials methodology demonstration projects. Available from: https://
                   www.ejprarediseases.org/funded-projects-demonstration/ [Last accessed on 17 Jun 2024].
               18.      EJP RD. Funded projects: internal call for innovation project in clinical trials methodology. Available from: https://www.
                   ejprarediseases.org/funded-projects-internal-call-for-innovation-project-in-clinical-trials-methodology/ [Last accessed on 17 Jun 2024].
               19.      Orphanet database. Knowledge on rare diseases and orphan drugs. Available from: www.orpha.net [Last accessed on 17 Jun 2024].
               20.      The EJP RD virtual platform. Available from: https://vp.ejprarediseases.org/ [Last accessed on 17 Jun 2024].
               21.      EJPRD. Virtual platform specification (VIPS) V2.0. Available from: https://www.ejprarediseases.org/wp-content/uploads/2023/05/
                   EJPRD_P2_AD49_PU_Virtual-Platform-Specification-V2.0.pdf [Last accessed on 17 Jun 2024].
               22.      EJP RD. FAIRification. Available from: https://www.ejprarediseases.org/fairification/ [Last accessed on 17 Jun 2024].
               23.      EJP RD. D11.11 additional facilities integrated to resources regarding data deposition and access, including user guidelines and
                   documentation for data deposition and access. Available from: https://www.ejprarediseases.org/wp-content/uploads/2021/03/EJPRD_
                   P2_D11.11_PU_First-ver_Addition-Facilities-Integrated-Resources_Data-Deposit-Access_FV.pdf [Last accessed on 17 Jun 2024].
               24.      EJP RD. D11.12 second version additional facilities integrated to resources regarding data deposition and access, including user
                   guidelines and documentation. Available from: https://www.ejprarediseases.org/wp-content/uploads/2021/03/EJPRD_P2_D11.12_PU_
                   2nd-ver_Addition-Facilities-Integrated-Resources_Data-Deposit-Access_VF.pdf [Last accessed on 17 Jun 2024].
               25.      EJP RD. D11.13 third version additional facilities integrated to resources regarding data deposition and access, including user
                   guidelines and documentation. Available from: https://www.ejprarediseases.org/wp-content/uploads/2022/01/EJPRD_P2_D11.13_PU_
                   3rd-ver_Addition-Facilities-Integrated-Resources_Data-Deposit-Access_VF.pdf [Last accessed on 17 Jun 2024].
               26.      EJP RD. D11.14 fourth version additional facilities integrated to resources regarding data deposition and access, including user
                   guidelines and documentation. Available from: https://www.ejprarediseases.org/wp-content/uploads/2023/02/EJPRD_P2_D11.14_PU_
                   4th-ver_Additional-Facilities-Integrated-Resources_Data-Deposit-Access_VF.pdf [Last accessed on 17 Jun 2024].
               27.      EJP RD. D11.15 fifth version additional facilities integrated to resources regarding data deposition and access, including user
                   guidelines and documentation. Available from: https://www.ejprarediseases.org/wp-content/uploads/2024/02/EJPRD_P2_D11.15_PU_
                   5th-ver_Additional-Facilities-Integrated-Resources_Data-Deposit-Access_VF.pdf [Last accessed on 17 Jun 2024].
               28.      EJP RD. D11.16 first report on processed genome-phenome datasets and multi-omics use cases analysed, including description of new
                   cloud and online analysis functionalities and tools. Available from: https://www.ejprarediseases.org/wp-content/uploads/2021/03/
                   EJPRD_P2_D11.16_PU_1st-Report-Processed-Genome-Phenome-Datasets-and-Multi-Omics-Use-Cases-Analysed_VF.pdf [Last
                   accessed on 17 Jun 2024].
               29.      EJP RD. D11.17 second report on processed genome-phenome datasets and multi-omics use cases analysed, including description of
                   new cloud and online analysis functionalities and tools. Available from: https://www.ejprarediseases.org/wp-content/uploads/2021/03/
                   EJPRD_P2_D11.17_PU_2nd-Report-Processed-Genome-Phenome-Datasets-Multi-Omics-Use-Cases-Analysed_VF.pdf [Last accessed
                   on 17 Jun 2024].
               30.      EJP RD. D11.18 third report on processed genome- phenome datasets and multi-omics use cases analysed, including description of
                   new cloud and online analysis functionalities and tools. Available from: https://www.ejprarediseases.org/wp-content/uploads/2022/01/
                   EJPRD_P2_D11.18_PU_3rd-Report-Processed-Genome-Phenome-Datasets-Multi-Omics-Use-Cases-Analysed_VF.pdf [Last accessed
                   on 17 Jun 2024].
               31.      EJP RD. D11.19 fourth report on processed genome-phenome datasets and multi-omics use cases analysed, including description of
                   new cloud and online analysis functionalities and tools. Available from: https://www.ejprarediseases.org/wp-content/uploads/2023/02/
                   EJPRD_P2_D11.19_PU_4th-Report-Processed-Genome-Phenome-Datasets-Multi-Omics-Use-Cases-Analysed_VF.pdf [Last accessed
                   on 17 Jun 2024].
               32.      EJP RD. D13.01 collection of (at least) 20 curated pathways in a (sub)portal on WikiPathways. Available from: https://www.
                   ejprarediseases.org/wp-content/uploads/2022/01/EJPRD_P2_D13.01_PU_Collection-of-curated-pathways-sub-Portal-WikiPathways_
                   VF.pdf. [Last accessed on 17 Jun 2024].
               33.      EJP RD. D13.2 completed pathway analysis workflow (data analysis including both types of genetic variant linking and network
                   creation). Available from: https://www.ejprarediseases.org/wp-content/uploads/2023/02/EJPRD_P2_D13.02-AD50-AD51_PU_
                   Completed-pathway-analysis-workflow.pdf [Last accessed on 17 Jun 2024].
               34.      EJP RD. Deliverable 13.3 completed network analysis workflow (active node detection, lifestyle factor network evaluation and
                   extended network analysis for drugs and toxic compounds). Available from: https://www.ejprarediseases.org/wp-content/uploads/
                   2024/02/EJPRD_P2_D13.03_PU_Completed-pathway-analysis-workflow-active-node-detection-lifestyle-factor-network-evaluation-
                   extended-network-analysis-for-drugs-toxic-compounds_VF.pdf [Last accessed on 17 Jun 2024].
               35.      ELIXIR service bundles for rare diseases. Systems biology service bundles for rare diseases. Available from: https://elixir-europe.org/
                   services/service-bundles/rare-diseases [Last accessed on 17 Jun 2024].
               36.      EJP RD. General information on training. Available from: https://www.ejprarediseases.org/general-information-training/ [Last
                   accessed on 17 Jun 2024].
               37.      EJP RD. Mentoring for translational research. Available from: https://www.ejprarediseases.org/mentoring/ [Last accessed on 17 Jun
                   2024].
               38.      EJP RD. AD40 report on training gaps identified and solutions proposed. Available from: https://www.ejprarediseases.org/wp-content/
   23   24   25   26   27   28   29   30   31   32   33